NOVEL AFLATOXIN AND FUNGAL INFECTION CONTROL METHODS

Compounds and methods for modulating TMPRSS6 expression

Therapeutic UNA oligomers and uses thereof

Bivalent siRNA chimeras and methods of use thereof

A METHOD OF REGULATING GENE EXPRESSION

Short interfering nucleic acid (siNA) compositions

Cationic lipid

Methods for therapeutic targeting of circulating tumor cells during hemodialysis

Novel linker, preparation method, and application thereof

Lipid compositions

REDUCTION OF TGF BETA SIGNALING IN MYELOID CELLS IN THE TREATMENT OF CANCER

Diagnostic and screening methods for atopic dermatitis

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

Organic compositions to treat EPAS1-related diseases

Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

Method for diagnosing and treating ovarian cancer

Down-regulating gene expression in insect pests

Oligonucleotide compounds for targeting huntingtin mRNA

EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS

METHOD FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS

RNA nanoparticles and method of use thereof

Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof

Lipids and compositions for the delivery of therapeutics

LDL QUANTITATION AND METHODS OF USE

METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE

TREATMENT OF EOSINOPHILIC INFLAMMATORY DISEASE

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Haploid induction compositions and methods for use therefor

COMPETITIVE MODULATION OF MICRORNAS

BACTERIAL MEDIATED THF ALPHA GENE SILENCING

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods of treating cancer

Oligonucleotide compositions with enhanced efficiency

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Anti-cancer RNA aptamers

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES

Anti-LILRB antibodies and their use in detecting and treating cancer

Polyvalent RNA-nanoparticle compositions

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

Methods for treating cancer with RORγ inhibitors

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

MULTI-CONJUGATE OF SIRNA AND PREPARING METHOD THEREOF

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

Compositions and methods for delivery of biomacromolecule agents

INTRACELLULAR DELIVERY SYSTEM AND METHODS

METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR

Homologous recombination factors

Recombinant protein-based method for the delivery of silencer RNA to target the brain

SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME

Dendronized polymers for nucleic acid delivery

Ionizable cationic lipid for RNA delivery

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORS

Compositions and methods of treating Fanconi Anemia

Methods to Accelerate Wound Healing in Diabetic Subjects

Compositions and methods for controlling

EML4-ALK FUSION GENE

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

Pharmaceutical composition for treating Charcot Marie Tooth disease

Compositions and methods for inhibition of expression of protein C (PROC) genes

RNA interference mediated therapy for neurodegenerative diseases

METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS

p63 inactivation for the treatment of heart failure

RNA products and uses thereof

Pharmaceutical composition for preventing and teating endocrine disrupting chemicals-induced diseases and treating method using the same

Biodegradable lipids for the delivery of active agents

NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM

Targeting ligands

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing

Assay for telomere length regulators

Nutlin-3a for Treatment of Proliferative Vitreoretinopathy

KUB5/HERA AS A DETERMINANT OF SENSITIVITY TO DNA DAMAGE

HER2-regulated RNA as a diagnostic and therapeutic targets in HER2+ breast cancer

MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS

Particle-nucleic acid conjugates and therapeutic uses related thereto

Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing

siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof

Compositions and methods for nucleic acid transfer

Hepcidin antagonists for use in the treatment of inflammation

CANCER THERAPEUTICS

Prevention and/or treatment of hearing loss or impairment

COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS

Methods of treating an overweight subject

Therapeutic nanoparticles and methods of use thereof

METHODS AND USES FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

THERAPEUTICS AND METHODS OF TREATING FATTY LIVER DISEASE

Cationic lipid

METHODS TO ENHANCE CELL-MEDIATED IMMUNITY

Inflammasome activation in myelodysplastic syndromes

Cholesteryl ester transfer protein (CETP) inhibition in the treatment of cancer

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases

Treatment of hyperhidrosis

Methods of treating cancer harboring hemizygous loss of TP53

Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA

Composition for treating cancer associated with HPV infection

Zn-DPA complex compounds and siRNA delivery systems containing the same

DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF

Car-expressing cells against multiple tumor antigens and uses thereof

Amphipathic peptide

Lipids and compositions for the delivery of therapeutics

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT

Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent

Beta-catenin inhibitors in cancer immunotherapy

Glycaspis Brimblecombei Control Agents

COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES

Antiperspirant composition

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

Short interfering RNA for treating cancer

Compositions and methods for inhibiting expression of the ALAS1 gene

CKAP4-molecular-targeted antitumor agent

COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors

COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

Method for improving learning

Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1

Replication capable rAAV vectors encoding inhibitory siRNA and methods of their use

Compositions and methods using capsids resistant to hydrolases

siRNA compounds comprising terminal substitutions

Method of treating a localized fibrotic disorder using an IL-33 antagonist

Methods and compositions for wound healing

2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

Anti-viral compositions containing PIKfyve inhibitors and use thereof

COATED CHITOSAN-BASED POLYPLEX FOR DELIVERY OF NUCLEIC ACIDS

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

Peptide/particle delivery systems

Technology for the Preparation of Microparticles

Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity

Compositions and methods for inhibiting gene expression of factor XII

Disulfide-containing alkyne linking agents

Double strand RNA as molecular biopesticides for RNA interference through feeding in the hemipteran invasive insect pest, brown marmorated stink bug

Variant RNAi

Long Non-Coding RNA For The Treatment Of Endothelial Dysfunction

Circular RNA For The Diagnosis Of Cardiovascular And Inflammatory Diseases

Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance

Compositions for modulating expression of C9ORF72 antisense transcript

DOUBLE STRAND RNA DELIVERY SYSTEM FOR PLANT-SAP-FEEDING INSECTS

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING METASTATIC CANCER

Biological Materials and Uses Thereof

Compositions and methods for regulating arterial tone

Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

FLIP - A SELECTIVE MOLECULAR TARGET OF SENESCENT CELLS

Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers

Compositions and methods for silencing hepatitis B virus gene expression

NOVEL BT TOXIN RECEPTORS AND METHODS OF USE

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

Method of producing enriched exosomes

INHIBITION OF PRMT5 TO TREAT MTAP-DEFICIENCY-RELATED DISEASES

Double-stranded ribonucleic acid as control against insects

Compositions and methods to promote erythropoiesis

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

Agents for improved delivery of nucleic acids to eukaryotic cells

Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells

Composition for reducing cellular senescence level including activity inhibitor inhibiting DCUN1D3 activity or expression inhibitor inhibiting expression of DCUN1D3-encoding gene and use thereof

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION

Pharmaceutical composition for preventing or treating diabetic complications and screening method for preventive or therapeutic agent for diabetic complications

Compositions and methods for reactivating latent immunodeficiency virus

C-Rel-specific siRNA and its use for preventing and treating autoimmune psoriasis

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

Compositions and methods for controlling

Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents

Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain

Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor

MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY

Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer

TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME AND DISEASES RELATED TO VASCULAR AGEING

ADAM12 inhibitors and their use against inflammation-induced fibrosis

Inhibin as targetable regulators of angiogenesis

FULLY STABILIZED ASYMMETRIC SIRNA

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

Reduction of off-target RNA interference toxicity

PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS

Method for modifying T cell population

HPV particles and uses thereof

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Anticancer therapeutic intervention

EGFR nucleic acids and uses thereof

Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition

TMPRSS6 iRNA compositions and methods of use thereof

USE OF RAD18 INHIBITORS IN THE TREATMENT OF TUMORS

PHARMACEUTICAL COMPOSITIONS COMPRISING MICRORNA

VLP WITH A FUSION PROTEIN

Formulations for targeted release of agents under low pH conditions and methods of use thereof

Nucleic acid, medical nanoparticle, and pharmaceutical composition thereof

METHODS FOR TREATING INFLAMMATORY ARTHRITIS

METHODS FOR PRODUCING DOPAMINERGIC NEURONS AND USES THEREOF

Methods and compositions for the treatment of retinopathy and other ocular diseases

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

Delivery across cell plasma membranes

Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles

Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Modulation of alternative MDM2 splicing

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

RNAI induced huntingtin gene suppression

Mitochondrial phosphate carrier targets for treating soft-tissue calcification

Inhibitors Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases

COLON DISEASE TARGETS AND USES THEREOF

Oligonucleotide having non-natural nucleotide at 5′-terminal thereof

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES

Methods and Compositions for Selecting siRNA of Improved Functionality

siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)

Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression

Hepatitis D virus (HDV) iRNA compositions and methods of use thereof

Hepatitis B virus (HBV) iRNA compositions and methods of use thereof

IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINE LEVELS WITH THE LONG NON-CODING RNA UMLILO

Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

Modified polycationic polymers

Combination therapies for inner ear sensory hair cell regeneration/replacement

Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications

METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

Method for preparing recombinant proteins through reduction of rnpA gene expression

PLANT PROTECTION FROM A PEST OR PATHOGEN BY EXPRESSION OF DOUBLE-STRANDED RNAs IN THE PLASTID

USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections

Structurally designed shRNAs

Cell penetrating stapled peptide, manufacturing method therefor, and use thereof

Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK

Inhibitors of cell adhesion

Methods and compositions for the activation of gamma-delta T-cells

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF

Methods and compositions for preventing ischemia reperfusion injury in organs

Nucleic acid molecules inducing RNA interference, and uses thereof

Compounds and methods for the modulation of COMP

RNA interference suppression of neurodegenerative diseases and methods of use

Methods for modulating ATRX-dependent gene repression

Bruton's tyrosine kinase as anti-cancer drug target

Cationic lipid

TLR9 TARGETED CYTOTOXIC AGENTS

Methods for treating and/or limiting development of diabetes

Polymers and polymeric nanogels with hydrophilics encapsulation and release capabilities and methods thereof

Nanoparticle

Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation

Organic compositions to treat Beta-ENaC-related diseases

Selective Reactivation of Genes on the Inactive X Chromosome

RNA interference mediating small RNA molecules

RNA-PROTEIN COMPLEX, AND RNA AND PROTEIN DELIVERY SYSTEM USING THE SAME

Sucrose ester based cationic gene vector and preparation method thereof

Efficient delivery of therapeutic molecules in vitro and in vivo

PH-sensitive peptides and their nanoparticles for drug delivery

Biotin complexes for treatment and diagnosis of Alzheimer'S disease

Methods and compositions for cell-proliferation-related disorders

Methods, systems, and compositions relating to MiRNA-146a

Oligonucleotide compositions with enhanced efficiency

Compositions and methods for inhibiting expression of transthyretin

SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION

Method for producing lipoplex for topical administration and antitumor agent using such lipoplex

Fusarium chitin synthase gene chs3b and the use thereof

Beta-catenin nucleic acids and uses thereof

Modulatory polynucleotides

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

AGENT FOR TREATING FIBROSIS OF THE INTESTINE

LncRNA and oncolytic adenovirus, and application thereof

Antibody for Recognizing Specific Motif of WLS Protein, and Pharmaceutical Composition Comprising Same

Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides

Branched oligonucleotides

ANDROGEN RECEPTOR NUCLEIC ACIDS AND USES THEREOF

Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA

Therapeutic inhibition of lactate dehydrogenase and agents therefor

METHODS FOR TREATING EYE DISORDERS

Method for controlling obesity using minimally invasive means

Hippo and dystrophin complex signaling in cardiomyocyte renewal

Single-stranded nucleic acid molecule for regulating expression of gene having delivering function

PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT, CONTAINING NDRG3 EXPRESSION OR ACTIVITY INHIBITOR AS ACTIVE INGREDIENT, OR NDRG3 PROTEIN-SPECIFIC ANTIBODY AND USE THEREOF

Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma

METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED OLIGONUCLEOTIDE

Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression

Treatment of hormonal disorders of growth

Use of alphavirus in preparation of antitumor drugs

Nucleic acids related to MiR-29B-1-5P and uses thereof

ANTI-TUMOR THERAPY

USE OF AGENTS FOR TREATING FAT-RELATED DISORDERS

LATS AND BREAST CANCER

Oligonucleotide targeted to the A20-3′ untranslated region

Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor

Treatment of HIV

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Organic compositions to treat HSF1-related diseases

Method For Screening Interfering Molecules

Intergenic RNAS and methods for modulating gene expression and pathogenesis in

NOVEL FUSION-CIRCULAR RNAs AND USES THEREOF

RNA interference agents for p21 gene modulation